Acadia Pharmaceuticals

Regional Account Manager, Pacific North West

United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, Rare DiseasesIndustries

Requirements

Candidates must live in Washington, Oregon, Alaska, or Utah and possess 5+ years of progressive business experience in the healthcare or biotech industry, including 3 years of field-based experience in account management, sales, and field reimbursement. A Bachelor's degree or higher is required, along with successful biotech/pharma product launch experience and experience in rare or niche markets with a documented track record of exceeding goals. Strong business relationships in GI/hepatology are desired, and experience in competitive marketplaces is preferred. Proven experience working within Hospitals, Academic Institutions, and clinics calling on interdisciplinary care teams is necessary, as is a track record of researching and problem-solving complex issues impacting HCPs while mitigating barriers to patient access to care. A proven record of success through collaborative teamwork and execution, along with a track record of operating in accordance with all regulations and company policies, is essential.

Responsibilities

The Regional Account Manager will own their regional business, focusing on increasing HCP awareness and understanding of promoted products. Responsibilities include identifying and establishing strong relationships with key thought leaders and customers, developing and implementing an effective go-to-market plan with short- and long-term business tactics, and identifying key priorities within territories. The role involves formulating and implementing an organizationally approved and compliant business plan, understanding healthcare trends in the Rare Disease community, applying strategies to mitigate account access challenges, and understanding the access process to facilitate patient care. The RAM will employ strong organizational and analytical skills to optimize growth, analyze business data, develop strategic business plans, and enhance the company's culture of compliance, integrity, and transparency. Additionally, they will develop and maintain strong partnerships across commercial, market access, compliance, and medical affairs functions, and drive change through influence and innovation.

Skills

New product launches
Business ownership
Leadership
Analytics
Go-to-market planning
Business tactics
Territory management
Presentation skills
Partner management
Relationship management

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI